Who Can Receive Neurovision™ Treatment?
The patient’s suitability is determined through a detailed eye examination.
Patients between the ages of 10-55, whose level of vision is above 15-20% and whose level of deviation is below 8 prism diopters and who have no other eye pathologies that may hinder vision, are considered to be suitable for treatment.
How is the Neurovision™ Treatment Administered?
The first session of the patient who is identified to be suitable for treatment is performed at the hospital by their physician. The treatment consists of approximately 40 sessions and each session lasts approximately 30-40 minutes. After the initial session applied by their ophthalmologist at the hospital, the patient may apply the rest of the treatment themselves through the computer programme provided to them, at home, or if they are able to create a suitable environment, at work. 1-2 sessions after beginning the Neurovision™ application, the patient’s level of vision is perceived by the program and, based on this data recorded in the computer, patient-specific exercises are generated after each session. The patient begins applying these exercises. The visual acuity and contrast sensitivity information entered into the system by the physician after monthly controls ensures the determination of the development of the customized treatment process.
Success in Neurovision™ Treatment
For the treatment to be successful, the sessions should be applied 3 days a week (every other day) for 40 minutes.
The physician’s control examination is necessary after the 5th, 10th, 20th and 40th sessions in order to observe the progress of the patient’s treatment. Results from the treatment can be achieved within 3-4 months through regular sessions and doctor’s control examinations.
Features of Neurovision™ Treatment
• It is a method administered for the treatment of amblyopia in people between the ages of 10-55.
• It is a non-surgical and medication free treatment method.
• It does not have any side effects and does not involve any risks for the patient.
• It is a US FDA (United States Food and Drug Administration) approved method.
• The application is easy and a significant part of it is performed at home.